THE FIRST AND ONLY
FDA-APPROVED
TREATMENT OF ITS KIND
CAMZYOS® is a cardiac myosin inhibitor that targets
the source of symptomatic obstructive HCM.
Stephanie, a symptomatic obstructive HCM patient, was compensated for her time.
CAMZYOS is a prescription medicine used to treat adults with symptomatic obstructive HCM and may improve both your symptoms and your ability to be active. If you're limiting your activities in hopes of avoiding oHCM symptoms, you deserve an opportunity to get back to those activities you love. Talk to your doctor and ask if CAMZYOS may be right for you.
CAMZYOS Works Differently
See how CAMZYOS works to target the source of obstructive HCM deep within the heart muscle.
To understand how CAMZYOS works, it's helpful to know how certain proteins help contribute to the pumping action of your heart:
Legend
Normal heart
Two proteins in the heart muscle, called myosin and actin, contribute to your heart pumping by connecting (making the heart contract) and releasing (allowing the heart to relax).
Heart with obstructive HCM
In obstructive HCM, myosin and actin form too many connections with each other, causing the heart to contract too much, which can make it difficult for it to relax.
How CAMZYOS works in a heart with obstructive HCM
CAMZYOS binds to myosin so that it “lets go” of actin, reducing the excessive connections between them. This action allows your heart muscle to relax more.
Why is it important to know how CAMZYOS works?
In people with symptomatic obstructive HCM, reducing the connections between myosin and actin
may decrease the obstruction and improve heart function (how the heart relaxes and fills with blood).
To learn more about CAMZYOS, please see U.S. Full Prescribing Information, including Boxed WARNING and Medication Guide.